A putative protein inhibitor of activated STAT (PIASy)interacts with p53 and inhibits p53-mediated transactivation but not apoptosis

Apoptosis

Volumn 6, Issue 3, 2001, Pages 221-234

  Nelson, V ^a   Davis, G E ^a   Maxwell, S A ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Apoptosis; H1299; P53; PIASy

Indexed keywords

DNA; LUCIFERASE; PROTEIN BAX; PROTEIN INHIBITOR; PROTEIN INHIBITOR OF ACTIVATED STAT; PROTEIN P21; PROTEIN P53; STAT PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LUNG NON SMALL CELL CANCER; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; TRANSACTIVATION; TWO HYBRID SYSTEM;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CARRIER PROTEINS; CELL LINE; CELL NUCLEUS; CELL SEPARATION; DNA; DNA DAMAGE; DNA-BINDING PROTEINS; FLOW CYTOMETRY; HUMANS; IMMUNOBLOTTING; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LUCIFERASES; LUNG NEOPLASMS; MICE; PLASMIDS; PRECIPITIN TESTS; PROTEIN BINDING; PROTEIN INHIBITORS OF ACTIVATED STAT; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS P21(RAS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STAT1 TRANSCRIPTION FACTOR; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; TWO-HYBRID SYSTEM TECHNIQUES;

MAMMALIA;

EID: 0035024007     PISSN: 13608185     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011392811628     Document Type: Article

References (48)

1. Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein
2. p53 functions as a cell cycle control protein in osteosarcomas
3. Growth arrest induced by wild-type p53 protein blocks cells prior to or near the restriction point in late G1 phase
4. Wild-type p53 functions as a control protein in the differentiation pathway of the B-cell lineage
5. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles
6. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53
7. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1
8. Suppression of p53 activity and p21WAF1/cip1 expression by vascular cell integrin alpha V beta 3 during angiogenesis
9. p53-mediated cell death: Relationship to cell cycle control
10. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B
11. Thymocyte apoptosis induced by p53-dependent and independent pathways
12. Down-regulation of wild-type p53 activity interferes with apoptosis of IL-3-dependent hematopoietic cells following IL-3 withdrawal
13. The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice
14. Database of p53 gene somatic mutations in human tumors and cell lines
15. Amplification of the gene encoding a p53-associated protein in human sarcomas
16. Oncoprotein MDM2 conceals the activation domain of the tumour suppressor p53
17. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
18. Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway
19. p53, the cellular gatekeeper for growth and division
20. p53: Puzzle and paradigm
21. The p53 pathway
22. The complexity of p53 modulation: Emerging patterns from divergent signals
23. Regulation of p53 downstream genes
24. A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage
25. Gas1-induced growth suppression requires a transactivation-independent p53 function
26. A function in apoptosis other than transactivation inherent in the NH2-terminal domain of p53
27. Function, oligomerization, and conformation of tumor-associated p53 proteins with mutated C-terminus
28. Activation of caspases in p53-induced transactivation-independent apoptosis
29. Wild-type but not mutant p53 suppresses the growth of human lung cancer cells bearing multiple genetic lesions
30. Transformation of intact yeast cells treated with alkali cations
31. Regulation of the yeast HO Gene
32. Single-step purification of shuttle vectors from yeast for high frequency back-transformation into E. coli
33. Expression of bax, bcl-2, waf-1, and PCNA gene products in an immortalized human endothelial celt line undergoing p53-mediated apoptosis
34. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei
35. Mutations in serines 15 and 20 of human p53 impair its apoptotic ability
36. Molecular and biological characterization of an ECV-304-derived cell line resistant to p53-mediated apoptosis
37. Inhibition of Stat1-mediated gene activation by PIAS1
38. Transient poly(ADP-ribosyl)ation of nuclear protein and role of poly(ADP-ribose) polymerase in the early stages of apoptosis
39. Role of poly(ADP-ribose) polymerase (PARP) cleavage in apoptosis. Caspase 3-resistant PARP mutant increases rates of apoptosis in transfected cells
40. Cleavage of automodified poly(ADP-ribose) polymerase during apoptosis. Evidence for involvement of caspase-7
41. Caspases: Intracellular signaling by proteolysis
42. A new player in cell death
43. Biological action of leptin as an angiogenic factor
44. STATs: Signal transducers and activators of transcripton
45. Regulation of IL-6 signaling by p53: Stat3-and Stat5-masking in p53-Val135-containing human hepatoma Hep3B cell lines
46. Thrombopoietin-induced conformational change in p53 lies downstream of the p44/p42 mitogen activated protein kinase cascade in the haman growth factor-dependent cell line M07e
47. p53 suppresses cytokine induced, Stat5 mediated activation of transcription
48. Activation of STAT transcription factors in oncogenic tyrosine kinase signaling